600521 华海药业
2023/09 - 九个月
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
2019/12
人民币(K¥)
经营活动产生之现金流量净额1,451,7211,242,693938,4301,555,4581,753,946
投资活动产生之现金流量净额(1,273,022)(2,432,575)(2,356,859)(1,357,542)(791,056)
筹资活动产生之现金流量净额(549,508)609,0431,118,346596,349(400,330)
汇率变动对现金及现金等价物的影响94,72654,654(43,491)(85,336)28,694
现金及现金等价物净增加/(减少)(276,083)(526,185)(343,574)708,930591,254
期初现金及现金等价物余额1,327,9501,854,1352,197,7091,488,779897,525
期末现金及现金等价物余额1,051,8671,327,9501,854,1352,197,7091,488,779